Improving access to COVID-19 rapid tests for people who inject drugs
Supported Employment to Create a Community Culture of COVID-19 Rapid Testing Among People Who Inject Drugs: PeerConnect2Test
This study is testing a new program that trains people who inject drugs to help their peers get COVID-19 rapid tests more easily.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 350 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Oregon Academic / other |
| Locations | 1 site (Eugene, Oregon) |
| Trial ID | NCT05984966 on ClinicalTrials.gov |
What this trial studies
This project focuses on enhancing the accessibility of rapid COVID-19 tests through a supported employment initiative called Peer Connect2Test (PeerC2T) for people who inject drugs (PWID). Participants will be recruited by a community partner that offers syringe exchange services and trained to become peer health workers (PHW) who will distribute SARS-CoV-2 rapid tests to their peers. The study aims to improve knowledge, self-efficacy, and health behaviors among PHWs, while also evaluating the impact of PeerC2T on testing uptake among other PWID using the RE-AIM framework. The overarching goal is to create a community-driven intervention that promotes widespread access to rapid testing among this vulnerable population.
Who should consider this trial
Good fit: Ideal candidates for this project are individuals aged 18 and older who inject drugs and can understand English.
Not a fit: Patients who do not inject drugs or are under 18 years old may not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could significantly increase COVID-19 testing rates and improve health outcomes for people who inject drugs.
How similar studies have performed: While similar community-engaged interventions have shown promise, this specific approach is relatively novel in the context of COVID-19 testing for PWID.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 and older, understand English Exclusion Criteria: -
Where this trial is running
Eugene, Oregon
- University of Oregon — Eugene, Oregon, United States (Recruiting)
Study contacts
- Study coordinator: Camille C Cioffi
- Email: ccioffi@uoregon.edu
- Phone: 541-346-4755
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.